Cargando…
Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis
BACKGROUND: Liver fibrosis is a major health problem worldwide and poses a serious obstacle for cell based therapies. Mesenchymal stem cells (MSCs) are multipotent and important candidate cells for future clinical applications however success of MSC therapy depends upon their homing and survival in...
Autores principales: | Ali, Gibran, Mohsin, Sadia, Khan, Mohsin, Nasir, Ghazanfar Ali, Shams, Sulaiman, Khan, Shaheen N, Riazuddin, Sheikh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419634/ https://www.ncbi.nlm.nih.gov/pubmed/22533821 http://dx.doi.org/10.1186/1479-5876-10-75 |
Ejemplares similares
-
Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice
por: Nasir, Ghazanfar Ali, et al.
Publicado: (2013) -
Mesenchymal Stem Cells Pretreated with HGF and FGF4 Can Reduce Liver Fibrosis in Mice
por: Shams, Sulaiman, et al.
Publicado: (2015) -
Mesenchymal stem cells conditioned with glucose depletion augments their ability to repair-infarcted myocardium
por: Choudhery, Mahmood S, et al.
Publicado: (2012) -
Preconditioning diabetic mesenchymal stem cells with myogenic medium increases their ability to repair diabetic heart
por: Khan, Mohsin, et al.
Publicado: (2013) -
Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice
por: Khan, Mohsin, et al.
Publicado: (2011)